Author
David A. Favor
Also Known As
D. A. FAVOR, D. A. Favor, David A. Favor, David A. Favor, Favor, D.A.
25
Publications
569
Citations
12
H-Index
34
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 7 | 7 | 212 |
2 | Biochemistry | 4 | 4 | 208 |
3 | Engineering | 3 | 3 | 198 |
4 | Natural Sciences | 3 | 3 | 197 |
5 | Biomolecular Engineering | 1 | 1 | 21 |
David A. Favor
×
14
Publications
534
Citations
11
H-Index
| Year | Citations | |
|---|---|---|
1999 | 132 | |
2008 | 102 | |
Chemically Diverse Group I p21-Activated Kinase (PAK) Inhibitors Impart Acute Cardiovascular Toxicity with a Narrow Therapeutic Window Joachim Rudolph, Lesley Murray, Chudi Ndubaku, Journal of Medicinal Chemistry Cardiovascular PharmacologyPharmacotherapyCardiovascular ToxicityDiverse GroupTumor Biology | 2016 | 74 |
2007 | 55 | |
1999 | 28 | |
2011 | 27 | |
1997 | 21 | |
2000 | 18 | |
2007 | 18 | |
2007 | 13 |
Page 1
Page 1